Group 1 - The company, Yian Technology, announced a credit impairment provision and asset impairment provision totaling approximately 11.31 million yuan, impacting the total profit for the reporting period by the same amount, while not affecting the operating cash flow for the period [1][1][1] - For the year 2024, Yian Technology's revenue composition is as follows: 91.96% from precision die-casting parts made of aluminum and magnesium alloys, 6.16% from organic silicone, and 1.88% from other businesses [1][1][1] - As of the report date, Yian Technology has a market capitalization of 10.8 billion yuan [1][1][1] Group 2 - The Chinese innovative drug sector has generated 80 billion USD in overseas licensing deals this year, indicating a robust secondary market for biomedicine, while the primary market is experiencing a fundraising slowdown [1][1][1]
宜安科技:公司计提信用减值准备及资产减值准备共约1131万元